WHO ICTRP trial
Validation of homoeopathic drugs for migraine
CTRI/2018/05/014140 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2018/05/014140 |
|---|---|
| Public title | Validation of homoeopathic drugs for migraine |
| Scientific title | Validation of commonly used homoeopathic drugs for migraine: A prospective observational study |
| Primary sponsor | Central Council for Research in Homoeopathy New Delhi Ministry of AYUSH Government of India |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- Migraine |
| Interventions | Intervention1: Individualized Homoeopathy: Selection of medicine will be guided by the presenting signs and symptoms, and individualization after repertorization. The prescription would finally be based on verified characteristic symptoms… |
| Registration date | May 25, 2018 |
| Target size | 200 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: